Artemide 01 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Artemide 01 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Artemide 01 Today - Breaking & Trending Today

Key Trials at ASCO 2023 Highlight Role of Perioperative Treatment Approaches in NSCLC

Jarushka Naidoo, MBBCh, discussed the clinical significance of datasets from several phase 3 trials presented at the 2023 ASCO Annual Meeting, including ADAURA, KEYNOTE-617, CheckMate 816, and CheckMate 9LA trials. ....

Jarushka Naidoo , Heather Wakelee , Stanford Health , European Medicines Agency , Royal College Of Surgeons Ireland Cancer Centre , News Network , Royal College , Surgeons Ireland Cancer Centre , Beaumont Hospital , Treating Field , Amivantamab Plus Lazertinib , Patients With Egfr Mutated Non Small Cell Lung Cancer , Checkmate 816 , Keynote 617 , Checkmate 9la , Artemide 01 , Keynote 789 ,

TIGIT, PD-1 Bispecific Rilvegostomig Shows Promise Following Prior Immunotherapy Resistance for Advanced PD-L1+ NSCLC

The PD-1 and TIGIT bispecific rilvegostomig demonstrated promising early signs of tolerability and efficacy in patients with advanced or metastatic PD-L1–positive non–small cell lung cancer following progression on at least 1 prior checkpoint inhibitor. according to initial findings from the phase 1/2 ARTEMIDE-01 study.
....

Kristoffer Staal Rohrberg , University Hospital Of Copenhagen , University Hospital , Asco Annual Meeting , Artemide 01 , Pd 1 And Tigit Bispecific Rilvegostomig ,